About Moderna (MRNA)
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technolog... Read more
- USD106.18
- USD108.19
- USD105.25
- USD142.79
- -3.80%
- 6.8B
- 3.10M
- 38.8B
- 62.55
- -21.30%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
